Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 October 2024 | Story Jacky Tshokwe | Photo Supplied
Dr Rosaline Sebolao
Dr Rosaline Sebolao, Teaching and Learning Manager in the Faculty of The Humanities at the University of the Free State, has been recognised with an award from Higher Education Resource Services South Africa (HERS-SA).

The University of the Free State (UFS) is proud to announce that Dr Rosaline Sebolao, our Teaching and Learning Manager in the Faculty of The Humanities, has been recognised with an award from Higher Education Resource Services South Africa (HERS-SA). At the ceremony, Dr Sebolao was one of the top five finalists for her exceptional contributions to higher education, particularly in academic administration.

The HERS-SA Award celebrates outstanding women in academic administration, acknowledging their crucial role in supporting and transforming the higher education landscape. According to Dr Sebolao, “The significance of this award lies in its developmental and transformative impact.” She explains that it highlights the essential contributions made by women in academic administration and encourages gender transformation within universities. This recognition empowers women to take on leadership roles, shifting the focus beyond traditional academic achievements.

Award recipients are selected based on a minimum of five years of demonstrated leadership in academic administration. Dr Sebolao’s innovative leadership practices, her contributions to institutional performance, her peer mentoring, and community engagement were all key criteria in her selection. Her mentoring efforts, particularly through school visits and support for underprivileged students, have made a lasting impact on the community and her peers.

Reflecting on the honour of receiving the award, Dr Sebolao describes it as “humbling and exciting”. She felt especially inspired as a mentor, noting that this recognition has the potential to encourage young women and men to strive for excellence in their academic and administrative pursuits.

Achievements leading to the award

In her role as Teaching and Learning Manager, Dr Sebolao has made significant contributions to both students and academics at the UFS. She has initiated several impactful projects, including the establishment of student indabas and entrepreneurial initiatives aimed at addressing graduate unemployment. Her commitment to improving communication led to the launch of a faculty newsletter, enhancing engagement among academics.

Among her most notable achievements is the Scholarship of Teaching and Learning (SoTL) project, which culminated in the UFS’ inaugural SoTL seminar in July 2024. She also spearheaded the Humanities Excellence Awards, encouraging faculty to pursue greater academic and research recognition. Her dedication to engaged scholarship extended beyond the university, resulting in community collaborations such as the establishment of a school library in Ikgomotseng, promoting literacy and education among local learners.

Dr Sebolao’s academic journey began after transitioning from the business sector to academia in 2013. Her experience in roles such as Peer Mentorship Coordinator and Teaching and Learning Coordinator at the Central University of Technology, and later as Manager of Special Projects in Teaching and Learning, helped shape her leadership style. She joined the UFS during the challenging COVID-19 period, a time that also marked some of her greatest achievements.

One of the key challenges that Dr Sebolao faced was overcoming the isolated nature of work within the faculty. By fostering a collaborative culture, she succeeded in promoting teamwork and innovation across departments. This approach not only improved institutional collaboration, but also strengthened her professional impact.

Dr Sebolao’s relationship with HERS-SA has been instrumental in her development as a leader in higher education. Since participating in the HERS-SA Academy in 2018, she has connected with influential women in the sector and solidified her commitment to mentoring others. Winning this award affirms the importance of mentoring and paves the way for future leaders in higher education.

Looking to the future, Dr Sebolao aspires to continue championing gender transformation in leadership. She aims to empower more women, particularly black women, to take on leadership roles within academia. Her focus is on fostering community development through collaborative projects that promote sustainable living, aligning with her broader vision for teaching and learning at the UFS.

Dr Sebolao encourages young women to believe in their abilities and seek mentorship for guidance and support. She emphasises that perseverance, coupled with a strong support network, is essential to achieving leadership success in higher education.

Outside of her professional life, Dr Sebolao draws motivation from her family and community work. Guided by Ecclesiastes 9:10, which emphasises dedication in all endeavours, and inspired by Mahatma Gandhi’s words, “Be the change you want to see in the world,” she remains committed to leading with passion and integrity.

The UFS community is incredibly proud of Dr Sebolao’s achievement and her continuous contributions to academic excellence and gender transformation in higher education. This award is a testament to her tireless efforts and dedication to empowering others.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept